While the strength of evidence for this "protective" effect is low, observers support further comparative effectiveness research in these patient groups.
Patients with comorbid T2D and heart failure may have a "distinct pathophysiology of the heart" say authors of a new study.
Findings from the REAL-CVD outcomes study reported at ACC.17 suggest class effect for cardioprotection.
Case-based quiz: Test your clinical judgement on optimal hypertension therapy for this complex patient at risk for hyperkalemia.
SMARTEX HF is first multicenter RCT to evaluate high intensity interval training in patients with HFrEF
Find out what you know about the log-awaited results of the cardiovascular safety trial--well received by some and soundly questioned by others.
What is the optimal treatment for hypertension when the patient also has Afib, CAD, or heart failure?
Quiz: The use of ACEIs and ARBs to treat hypertension in moderate-to-severe kidney disease is a murky area of medicine. Test what you know, here.
Study questions whether reduction in AF burden after catheter ablation leads to sustained beneficial cardiac remodeling.